ArticleeLife2022
A human-based multi-gene signature enables quantitative drug repurposing for metabolic disease.
James A Timmons et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleeLife2022
James A Timmons et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.